Simultaneous determination of FLZ and its metabolite (M1) in human plasma and urine by UHPLC-MS/MS: Application to a pharmacokinetic study.

Journal of Pharmaceutical and Biomedical Analysis(2019)

引用 3|浏览5
暂无评分
摘要
•A rapid and sensitive UHPLC-MS/MS method was developed for the simultaneous determination of FLZ and M1.•The method was fully validated and successfully applied to a first-in-human clinical study.•The PK profiles and excretory fraction in urine were obtained in Chinese healthy subjects for the first time.
更多
查看译文
关键词
FLZ,Parkinson’s disease,Human plasma and urine,UHPLC-MS/MS
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要